Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period
Moolec Science has regained compliance with all Nasdaq Capital Market continued listing requirements within the remediation period granted by the Nasdaq Hearings Panel.
The company reported stockholders' equity of approximately $11.3 million as of March 31, 2026, down from $15.2 million as of December 31, 2025.
Moolec expects to notify the holder to convert the remaining $4.0 million of the original aggregate preference share amount within the next 12 months, which is expected to further strengthen stockholders' equity.